Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Male Paediatric Fertility Restoration using Testis Organoids

Project description

Lab-grown testis models to restore pre-puberty male fertility

Infertility is a significant but often overlooked consequence of life-saving cancer treatments, particularly for boys who have not yet reached puberty. Unlike adults, they cannot freeze sperm before chemotherapy, leaving them with no fertility restoration options later in life. The ERC-funded Restore-Fertility project aims to create human testis organoids, namely tiny, lab-grown testis models from tissue biopsies taken prior to chemotherapy. Building on successful results in mice, researchers will study whether these organoids can replicate the testis environment and initiate sperm production. Project findings could pave the way for innovative clinical solutions to help childhood cancer survivors regain fertility in adulthood.

Objective

Chemotherapy treatments for cancer and haematological disorders can lead to male infertility. While adult males can freeze a sperm biopsy prior to chemotherapy, pre-pubertal children cannot do so, as they do not yet produce sperm. Reaching 88% survival rate for paediatric cancers nowadays, many of these kids will survive to adulthood but remain infertile. There are currently no clinical fertility
restoration options available for these kids. Many of them are advised to undergo a testis biopsy procedure for fertility preservation prior to chemotherapy, with the hope that techniques will be developed to allow the use of these samples for future sperm production.
Within the ERC StG, we aimed to develop an in vitro system that can closely model the testis. As such, we have recently published the development of testis organoids from both embryonic and prepubertal mouse testis. These organoids can be cultured in vitro for 9 weeks, while preserving all cell types normally present in the testis. These organoids highly recapitulate the in vivo state by creating
structures, as well as presenting expression profiles, of in vivo testis. We developed defined media composition for in vitro maturation. Finally, we show indications that meiosis is initiated in vitro within the organoids.
In this ERC PoC, building on our development in the mouse, we will generate human testis organoids derived from pre-pubertal testis biopsies that were obtained prior to chemotherapy treatment. We will assess the ability of these testicular cells to create human testis organoids, and analyse the structure, transcriptome, as well as ability to initiate, and potentially complete, meiosis. Within Restore-
Fertility, we aim to achieve significant progress with the technology development in human samples, and provide a proof-of-concept for sperm production in vitro. We will also achieve business progression by consolidating IP strategy, market analysis, and develop a comprehensive business strategy.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

BAR ILAN UNIVERSITY
Net EU contribution
€ 150 000,00
Address
BAR ILAN UNIVERSITY CAMPUS
52900 Ramat Gan
Israel
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)